StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
108
This year
16
Publishing Date
2024 - 02 - 14
2
2023 - 11 - 11
2
2023 - 10 - 23
2
2023 - 08 - 30
2
2023 - 08 - 25
3
2023 - 07 - 08
2
2023 - 05 - 12
1
2023 - 05 - 11
1
2023 - 05 - 08
1
2023 - 04 - 20
1
2023 - 04 - 13
1
2023 - 04 - 03
1
2023 - 03 - 27
1
2023 - 03 - 22
1
2023 - 03 - 11
1
2023 - 03 - 10
1
2023 - 03 - 06
1
2023 - 03 - 04
1
2023 - 02 - 24
1
2023 - 02 - 23
1
2023 - 02 - 22
1
2023 - 02 - 20
1
2023 - 02 - 15
1
2023 - 02 - 11
1
2023 - 02 - 09
1
2023 - 02 - 03
1
2023 - 01 - 30
1
2023 - 01 - 12
1
2023 - 01 - 10
1
2023 - 01 - 04
1
2022 - 12 - 30
2
2022 - 12 - 22
1
2022 - 12 - 07
1
2022 - 12 - 06
2
2022 - 11 - 28
2
2022 - 11 - 23
1
2022 - 11 - 21
1
2022 - 11 - 10
1
2022 - 11 - 07
1
2022 - 11 - 03
2
2022 - 11 - 02
2
2022 - 10 - 19
1
2022 - 10 - 14
1
2022 - 10 - 11
1
2022 - 09 - 30
1
2022 - 09 - 28
1
2022 - 09 - 26
1
2022 - 09 - 20
1
2022 - 09 - 19
1
2022 - 09 - 16
1
2022 - 09 - 13
1
2022 - 09 - 08
1
2022 - 08 - 24
1
2022 - 08 - 16
1
2022 - 08 - 08
1
2022 - 08 - 03
1
2022 - 08 - 02
1
2022 - 07 - 26
1
2022 - 07 - 25
1
2022 - 07 - 19
1
Sector
Consumer non-durables
1
Distribution services
1
Health services
1
Health technology
108
Manufacturing
12
N/a
10
Process industries
4
Producer manufacturing
3
Professional, scientific, and technical services
1
Technology services
1
Tags
Agreement
11
Alliances
24
America
28
Antibody
19
Astrazeneca
14
Biotech
28
Breast
11
Breast cancer
13
Cancer
144
Cell
14
Clinical-trials-phase-iii
16
Collaboration
14
Covid-19
8
Diabetes
16
Diagnostic
10
Diagnostics
11
Disease
34
Drug
69
Drug delivery
12
Enhertu
24
Europe
11
Expected
13
Fda
9
Financial
10
Financial results
9
Global
108
Granted
8
Growing
24
Growth
120
Health
9
Her2
27
Her2-
18
Immunotherapy
10
Iot
8
License
16
Liver
18
Lung
24
Lung cancer
10
Market
265
Metastatic breast cancer
11
N/a
514
Partnership
8
People
10
Pharma
10
Positive
13
Reach
20
Regulatory
8
Report
95
Research
73
Respiratory
12
Results
30
Review
11
Set
14
System
9
Technology
10
Therapeutics
70
Therapy
32
Treatment
46
Trial
52
Vaccine
29
Entities
3m company
3
Abbott laboratories
21
Abbvie inc.
21
Adaptimmune therapeutics plc
1
Adma biologics inc
1
Agilent technologies, inc.
1
Albemarle corporation
2
Alkermes plc
1
Amgen inc.
24
Amryt pharma plc
1
Aptargroup, inc.
2
Arma services inc
1
Astellas pharma inc
6
Astrazeneca plc
108
Atara biotherapeutics, inc.
1
Aurinia pharmaceuticals inc
1
Aveo pharmaceuticals, inc.
1
Bausch health companies inc.
1
Baxter international inc.
5
Becton, dickinson and company
1
Bio-rad laboratories, inc.
1
Biogen inc.
6
Biontech se
2
Boston scientific corporation
1
Bristol-myers squibb company
20
Catalent, inc.
1
Celyad oncology sa
1
Clovis oncology, inc.
1
Csl ltd
2
Cumberland pharmaceuticals inc.
1
Davita inc.
1
Diffusion pharmaceuticals inc.
1
Eli lilly and company
34
Endo international plc
3
Entera bio ltd.
1
Erasca inc
1
Exelixis, inc.
1
Fusion pharmaceuticals inc.
1
Galapagos nv
1
Galectin therapeutics inc.
1
Galmed pharmaceuticals ltd.
1
Generex biotechnology corp
1
Genfit s.a.
1
Gilead sciences, inc.
5
Glaxosmithkline plc
45
Grifols sa
1
Iovance biotherapeutics, inc.
2
Ironwood pharmaceuticals, inc.
2
Jazz pharmaceuticals plc
2
Johnson & johnson
31
Koninklijke philips n.v.
3
Novartis ag
44
Novo nordisk a/s
12
Perrigo company
2
Pfizer, inc.
14
Sanofi
54
Takeda pharmaceutical company limited
13
Teva pharmaceutical industries ltd
27
Thermo fisher scientific inc
4
Viatris inc.
5
Symbols
A
88
AAPL
138
ABB
209
ABBNY
85
ABBV
113
ABLZF
209
ABT
349
AMGN
83
ARVL
146
AZN
108
AZNCF
104
BDX
159
BEEM
123
BIO
110
BSX
116
CSCO
134
DD
86
DHR
163
DNZOF
113
DNZOY
113
EMN
79
ERIC
183
FNCTF
218
GE
197
GLAXF
159
GOOG
91
GOOGL
90
GSK
159
HON
287
IBM
97
IFNNF
100
IFNNY
100
INTC
184
JNJ
422
LLY
149
LMT
147
MDT
223
MMM
215
MS
246
MSFT
258
NIPNF
109
NOC
112
NVDA
90
NVS
229
NVSEF
228
ORCL
207
PCRFF
184
PCRFY
184
PHG
200
QGEN
77
SAP
172
SAPGF
171
SNY
356
SNYNF
356
SPGI
149
SYK
100
TEVJF
111
TMO
281
TRUMF
82
TRUMY
82
Exchanges
Amex
1
Nasdaq
108
Nyse
95
Crawled Date
2024 - 03 - 08
2
2024 - 02 - 14
2
2023 - 11 - 11
2
2023 - 10 - 23
2
2023 - 08 - 30
2
2023 - 08 - 25
3
2023 - 08 - 23
2
2023 - 07 - 08
2
2023 - 05 - 11
1
2023 - 05 - 08
1
2023 - 04 - 20
1
2023 - 04 - 13
1
2023 - 04 - 03
1
2023 - 03 - 27
1
2023 - 03 - 23
1
2023 - 03 - 11
2
2023 - 03 - 06
1
2023 - 03 - 04
1
2023 - 02 - 24
1
2023 - 02 - 23
1
2023 - 02 - 22
1
2023 - 02 - 20
1
2023 - 02 - 15
1
2023 - 02 - 11
1
2023 - 02 - 09
1
2023 - 02 - 03
1
2023 - 01 - 30
1
2023 - 01 - 12
1
2023 - 01 - 10
1
2023 - 01 - 04
1
2022 - 12 - 30
2
2022 - 12 - 22
1
2022 - 12 - 07
1
2022 - 12 - 06
2
2022 - 11 - 28
2
2022 - 11 - 23
1
2022 - 11 - 21
1
2022 - 11 - 10
1
2022 - 11 - 07
1
2022 - 11 - 03
2
2022 - 11 - 02
2
2022 - 10 - 19
1
2022 - 10 - 14
1
2022 - 10 - 11
1
2022 - 09 - 30
1
2022 - 09 - 28
1
2022 - 09 - 26
1
2022 - 09 - 20
1
2022 - 09 - 19
1
2022 - 09 - 16
1
2022 - 09 - 13
1
2022 - 09 - 08
1
2022 - 08 - 24
1
2022 - 08 - 16
1
2022 - 08 - 08
1
2022 - 08 - 03
1
2022 - 08 - 02
1
2022 - 07 - 26
1
2022 - 07 - 25
1
2022 - 07 - 19
1
Crawled Time
00:00
5
00:20
1
01:00
6
02:00
7
04:20
6
06:00
2
08:00
1
09:00
1
10:00
3
11:00
3
12:00
5
13:20
2
14:00
3
14:20
1
14:30
1
15:00
5
15:20
3
15:30
1
16:00
5
16:20
1
17:00
9
18:00
5
19:00
7
20:00
5
21:00
6
22:00
8
23:00
6
Source
www.biospace.com
1
www.globenewswire.com
2
www.prnewswire.com
105
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Global
symbols :
AZN
save search
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published:
2024-03-11
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.45%
|
O:
2.01%
H:
0.0%
C:
-2.01%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.19%
|
O:
1.12%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-7.74%
|
O:
0.02%
H:
0.79%
C:
0.79%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
2.23%
|
O:
0.9%
H:
2.03%
C:
1.89%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.02%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.84%
|
O:
0.01%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.88%
|
O:
-0.19%
H:
0.22%
C:
-0.21%
global
set
growth
market
Global Dyslipidemia Drugs Market Set to Reach $30.98 Billion by 2034 with Statins Dominating and PCSK9 Inhibitors Showing Rapid Growth
Published:
2024-03-08
(Crawled : 18:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.68%
|
O:
3.21%
H:
0.0%
C:
-1.71%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.42%
|
O:
-0.68%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.38%
|
O:
-0.08%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.13%
|
O:
-0.03%
H:
0.62%
C:
0.5%
rapid
reach
global
set
growth
market
Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published:
2024-03-07
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.68%
|
O:
3.21%
H:
0.0%
C:
-1.71%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.85%
|
O:
0.08%
H:
0.86%
C:
0.7%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.42%
|
O:
-0.68%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.77%
|
O:
-0.02%
H:
0.0%
C:
-2.29%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-11.4%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.38%
|
O:
-0.08%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.13%
|
O:
-0.03%
H:
0.62%
C:
0.5%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.9%
|
O:
-0.02%
H:
1.37%
C:
0.34%
company
report
global
market
Cervical Cancer Global Clinical Trials Review 2024: Clinical Trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
Published:
2024-03-01
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.32%
|
O:
0.01%
H:
0.0%
C:
-0.43%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
6.85%
|
O:
0.59%
H:
2.06%
C:
2.06%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.17%
|
O:
-1.27%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
6.4%
|
O:
0.28%
H:
0.75%
C:
0.4%
review
cancer
trials
global
trial
Ionis announces new chief global product strategy officer to lead next phase of commercial growth
Published:
2024-02-29
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
3.29%
|
O:
-3.11%
H:
0.0%
C:
-0.24%
IONS
|
$40.64
-0.42%
-0.42%
850K
|
Health Technology
|
-12.31%
|
O:
0.82%
H:
0.33%
C:
-3.64%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.46%
|
O:
-0.28%
H:
0.06%
C:
-1.55%
global
commercial
growth
Global Glucagon-Like Peptide 1 (GLP-1) Agonist Market Analysis Report 2024: A $133.5 Billion in 2030 Featuring Eli Lilly and Co, Pfizer, Sanofi, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk
Published:
2024-02-27
(Crawled : 01:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.09%
|
O:
-1.72%
H:
2.54%
C:
2.54%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.74%
|
O:
-2.2%
H:
2.39%
C:
1.34%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.76%
|
O:
-0.94%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.54%
|
O:
0.01%
H:
0.79%
C:
0.6%
report
agonist
global
market
Global Incretin Based Drugs Research Report 2023: Market to Reach $64.28 Billion by 2029 from $40 Billion in 2022, Driven by Increasing Prevalence of Diabetes
Published:
2024-02-21
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
5.3%
|
O:
-0.88%
H:
1.75%
C:
-0.29%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.38%
|
O:
-0.65%
H:
0.62%
C:
0.5%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-0.65%
|
O:
-2.33%
H:
1.55%
C:
1.06%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.96%
|
O:
-1.01%
H:
1.1%
C:
1.1%
report
reach
research
global
diabetes
market
9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published:
2024-02-19
(Crawled : 16:00)
- prnewswire.com
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
cancer
cell
global
growth
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$563.5
-19.1%
6
|
Health Technology
|
12.7%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
9.56%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$55.65
0.02%
32K
|
Professional, Scientific, and T...
|
15.41%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-1.04%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.3%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.08%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-4.32%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
1.05%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
0.2%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.33%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.49%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.43%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
News
|
$29.095
0.64%
0.64%
87K
|
Health Technology
|
-25.19%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.85%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-8.79%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published:
2024-02-14
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
9.56%
|
O:
0.87%
H:
0.21%
C:
-2.23%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-4.32%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
1.05%
|
O:
0.38%
H:
2.44%
C:
1.54%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.07%
|
O:
0.56%
H:
0.49%
C:
-0.12%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.43%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.85%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-8.79%
|
O:
-0.21%
H:
0.34%
C:
0.07%
disease
report
treatment
expansion
global
infections
market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published:
2024-02-12
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
9.56%
|
O:
-0.57%
H:
0.04%
C:
-1.74%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.87%
|
O:
-1.46%
H:
1.04%
C:
0.97%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
1.43%
|
O:
0.09%
H:
0.0%
C:
-0.48%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-3.03%
|
O:
0.02%
H:
0.46%
C:
-0.14%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.62%
|
O:
-0.83%
H:
0.7%
C:
-0.27%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.21%
|
O:
-0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.34%
|
O:
-0.86%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
9.65%
|
O:
-1.77%
H:
0.46%
C:
0.41%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-8.99%
|
O:
-0.4%
H:
1.6%
C:
1.54%
report
health
treatment
care
global
market
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published:
2024-02-09
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-12.38%
|
O:
-0.91%
H:
3.88%
C:
3.88%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
8.24%
|
O:
-2.6%
H:
2.26%
C:
1.44%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-9.35%
|
O:
-2.46%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-12.95%
|
O:
4.66%
H:
0.0%
C:
-3.92%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-7.8%
|
O:
-0.04%
H:
0.11%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.17%
|
O:
-0.37%
H:
0.21%
C:
0.05%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.31%
|
O:
0.33%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.26%
|
O:
1.11%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
7.47%
|
O:
-1.28%
H:
1.05%
C:
-0.72%
research
global
market
Global Respiratory Disease Vaccine Market Set for Growth, Fueled by Aging Populations and Vaccine Mandates - Trends, Opportunities, and Forecasts, 2018-2028F
Published:
2024-01-22
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-8.68%
|
O:
1.71%
H:
0.0%
C:
-0.15%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
2.66%
|
O:
2.63%
H:
0.8%
C:
0.75%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.97%
|
O:
0.6%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.18%
|
O:
-0.21%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.59%
|
O:
1.8%
H:
0.14%
C:
-0.89%
disease
vaccine
respiratory
global
set
market
Global Orphan Drugs Market Research Report 2023: Market to Reach $415.2 Billion by the End of 2028 - Premium Pricing of Orphan Drugs and Increasing Collaborations/Licensing Agreements Bolsters Growth
Published:
2024-01-17
(Crawled : 20:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-9.12%
|
O:
0.1%
H:
0.76%
C:
0.76%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
0.97%
|
O:
1.06%
H:
0.0%
C:
-2.34%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-12.65%
|
O:
0.0%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-20.38%
|
O:
-0.6%
H:
0.34%
C:
0.34%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-14.02%
|
O:
-0.78%
H:
0.59%
C:
0.57%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.56%
|
O:
-0.21%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
1.93%
|
O:
-0.54%
H:
1.55%
C:
1.33%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.87%
|
O:
-1.1%
H:
1.63%
C:
1.59%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.04%
|
O:
-0.51%
H:
1.33%
C:
0.93%
report
reach
research
global
growth
market
Advancing Melanoma Therapeutics: Global Market Insights and In-depth Analysis by BCC Research
Published:
2024-01-12
(Crawled : 11:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-1.25%
|
O:
2.07%
H:
0.0%
C:
-0.06%
ERAS
|
$1.79
0.0%
570K
|
|
-1.03%
|
O:
0.0%
H:
4.62%
C:
-1.03%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-13.49%
|
O:
-0.16%
H:
0.43%
C:
0.02%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-1.32%
|
O:
0.25%
H:
0.36%
C:
0.1%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-12.59%
|
O:
0.71%
H:
0.56%
C:
0.42%
melanoma
research
global
market
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
Published:
2024-01-02
(Crawled : 14:00)
- prnewswire.com
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.36%
|
O:
-0.76%
H:
2.65%
C:
2.33%
license
astrazeneca
global
program
therapeutics
agreement
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published:
2023-12-22
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.25%
|
O:
3.66%
H:
0.0%
C:
-0.12%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
3.68%
|
O:
3.33%
H:
0.0%
C:
-2.93%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
20.34%
|
O:
-0.31%
H:
0.39%
C:
-0.44%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.58%
|
O:
1.09%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
31.25%
|
O:
0.18%
H:
0.5%
C:
-0.46%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-5.77%
|
O:
-0.78%
H:
5.15%
C:
2.81%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
8.24%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.61%
|
O:
1.03%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
7.04%
|
O:
0.52%
H:
0.58%
C:
0.05%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-15.24%
|
O:
0.34%
H:
1.02%
C:
0.59%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-23.13%
|
O:
0.57%
H:
1.36%
C:
1.04%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.96%
|
O:
1.06%
H:
0.18%
C:
-1.06%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-5.15%
|
O:
0.24%
H:
2.03%
C:
1.49%
patent
report
global
market
Global Enterprise Artificial Intelligence Market Forecast Report: Enterprise AI Market to Surge, Predicted to Hit $1.89 Billion by 2030
Published:
2023-11-13
(Crawled : 10:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
2.42%
|
O:
-0.12%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
8.87%
|
O:
-0.23%
H:
0.6%
C:
0.6%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.19%
|
O:
-1.48%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
8.07%
|
O:
0.06%
H:
1.08%
C:
0.78%
intelligence
global
market
Global NASH Market to Soar to $2.71 Billion by 2023, Driven by Rising Prevalence of Silent Liver Disease
Published:
2023-11-11
(Crawled : 04:20)
- prnewswire.com
IVA
|
$3.35
-2.9%
-2.99%
8.5K
|
Health Technology
|
Email alert
Add to watchlist
GALT
|
$3.37
-0.3%
-0.3%
210K
|
Health Technology
|
Email alert
Add to watchlist
GNFT
|
$3.59
4.03%
2.1K
|
Health Technology
|
Email alert
Add to watchlist
ICPT
|
$19.0
-0.05%
4M
|
Health Technology
|
Email alert
Add to watchlist
IVEVF
|
$3.73
0%
1K
|
n/a
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
MDGL
|
$212.33
-4.47%
-4.68%
620K
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
GLMD
|
$0.3787
-0.41%
18K
|
Health Technology
|
Email alert
Add to watchlist
liver
disease
global
nash
market
Global Glucagon-like Peptide 1 (GLP-1) Market Report 2023: Key Players Include Pfizer Inc., AstraZeneca PLC, Sanofi, Novo Nordisk Among Others
Published:
2023-11-11
(Crawled : 04:20)
- prnewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
report
astrazeneca
global
market
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.